| Dr Damon Isamu Masaki, MD | |
|
2011 Pinto Ln, Suite 200, Las Vegas, NV 89106-4004 | |
| (702) 382-3200 | |
| (702) 382-3575 |
| Full Name | Dr Damon Isamu Masaki |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 2011 Pinto Ln, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598712275 | NPI | - | NPPES |
| 12209 | Other | NV | MEDICAL LICENSE |
| G45365 | Other | CA | CALIFORNIA STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 12209 (Nevada) | Primary |
| Entity Name | Magella Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376640086 PECOS PAC ID: 7214827591 Enrollment ID: O20040318001666 |
News Archive
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
A recent observational study reported in the journal Circulation ("Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults") needs to be considered in the proper scientific context, especially in relation to other previously published research that has reached the opposite conclusion.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
People who inject illicit drugs can develop potentially deadly infections of the heart, blood, joints and soft tissues.
SEI today announced that one of the company's institutional clients - Meda Pharmaceuticals - was recognized with the "Solutions Superstar" award by EmployersWeb. The award honors Meda for their outstanding and innovative defined benefit plan management including asset allocation changes and strategies aimed at matching the duration of invested assets with the plan's liabilities.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Damon Isamu Masaki, MD 2011 Pinto Ln, Suite 200, Las Vegas, NV 89106-4004 Ph: (702) 382-3200 | Dr Damon Isamu Masaki, MD 2011 Pinto Ln, Suite 200, Las Vegas, NV 89106-4004 Ph: (702) 382-3200 |
News Archive
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
A recent observational study reported in the journal Circulation ("Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults") needs to be considered in the proper scientific context, especially in relation to other previously published research that has reached the opposite conclusion.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
People who inject illicit drugs can develop potentially deadly infections of the heart, blood, joints and soft tissues.
SEI today announced that one of the company's institutional clients - Meda Pharmaceuticals - was recognized with the "Solutions Superstar" award by EmployersWeb. The award honors Meda for their outstanding and innovative defined benefit plan management including asset allocation changes and strategies aimed at matching the duration of invested assets with the plan's liabilities.
› Verified 5 days ago
Dr. Geoffrey Hsieh, M.D Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 700 Shadow Ln Ste 370, Las Vegas, NV 89106 Phone: 702-693-6870 Fax: 702-693-6899 | |
Jeffrey Ta Liu, MD - LLC Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3040 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-477-0707 Fax: 888-232-5937 | |
Leslie L Zak, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2851 N Tenaya Way, Suite 208, Las Vegas, NV 89128 Phone: 702-228-0319 Fax: 702-477-0254 | |
Jennifer Wong, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2880 N Tenaya Way Ste 420, Las Vegas, NV 89128 Phone: 702-255-2022 Fax: 702-255-8810 | |
Dr. Navkaran B Singh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9280 W Sunset Rd Ste 400, Las Vegas, NV 89148 Phone: 702-366-1268 Fax: 702-366-7079 | |
Dr. Jessica B Colwill, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8906 Spanish Ridge Ave Ste 202, Las Vegas, NV 89148 Phone: 702-577-1622 Fax: 702-912-4994 | |
Dr. Staci Leigh Mchale, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8850 W Sunset Rd, Suite #110, Las Vegas, NV 89148 Phone: 702-740-0500 Fax: 702-740-0502 |